Safety and tolerability of Aviandr (maritupirdine) in long-term therapy of generalized anxiety disorder: results of a 36-week post-marketing observational study

Marina Arkadievna Kinkulkina; Beatrice A. Volel; Е. А. Smolyarchuk; Morozov En; Alexandre V. Ivachtchenko; Ilya A. Ivashchenko; Nikolay N. Ivanets; T I Avdeeva; Yu G Tikhonova; T. A. Izyumina; P. A. Belyaeva; Viktoriya Dedkova; Измайлова О. В.; D.A. Golovkina; E. M. Goncharova; D. S. Gorchakov; Andrey A. Ivaschenko; A.E. Morozov; Vadim V. Tarasov

doi:10.14412/2074-2711-2026-5-58-65

SCHEDA SCIENTIFICA2026Studio osservazionale

Safety and tolerability of Aviandr (maritupirdine) in long-term therapy of generalized anxiety disorder: results of a 36-week post-marketing observational study

Marina Arkadievna Kinkulkina, Beatrice A. Volel, Е. А. Smolyarchuk, Morozov En, Alexandre V. Ivachtchenko, Ilya A. Ivashchenko, Nikolay N. Ivanets, T I Avdeeva, Yu G Tikhonova, T. A. Izyumina, P. A. Belyaeva, Viktoriya Dedkova, Измайлова О. В., D.A. Golovkina, E. M. Goncharova, D. S. Gorchakov, Andrey A. Ivaschenko, A.E. Morozov, Vadim V. Tarasov

Neurology neuropsychiatry Psychosomatics · 2026

Psicologia clinica Psicoterapia Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major DepressionPharmacovigilance and Adverse Drug Reactionsgeneralized anxiety disorderlong-term treatmentdrug safetytolerabilityadverse eventsdaytime sleepinesswithdrawal syndromeelderly patientssomatic comorbiditymedication adherencerelapse prevention

Come citare questo studio

Marina Arkadievna Kinkulkina, Beatrice A. Volel, Е. А. Smolyarchuk, Morozov En, Alexandre V. Ivachtchenko, Ilya A. Ivashchenko, Nikolay N. Ivanets, T I Avdeeva, Yu G Tikhonova, T. A. Izyumina, P. A. Belyaeva, Viktoriya Dedkova, Измайлова О. В., D.A. Golovkina, E. M. Goncharova, D. S. Gorchakov, Andrey A. Ivaschenko, A.E. Morozov, Vadim V. Tarasov. (2026). Safety and tolerability of Aviandr (maritupirdine) in long-term therapy of generalized anxiety disorder: results of a 36-week post-marketing observational study. Neurology neuropsychiatry Psychosomatics. DOI: 10.14412/2074-2711-2026-5-58-65

Consulta la pubblicazione originale ↗